Location: Home
  • search
  • go
  • Relate News
  • 1/27/2010Pacgen and New Summit Biopharma reach agreement to develop oral candid...
  • 1/20/2010China to improve market access to India pharma companies
  • 1/19/2010Certain high blood pressure drugs may be useful in diabetic eye diseas...
  • 1/12/2010Pfizer partners with India's Strides Arcolab to expand generic drug bu...
  • 12/15/2009SFDA approves recombinant insulin of United Labs
  • 11/11/2009Novartis freezes R&D in India due to IP frustrations
  • 10/26/2009Shanghai Huayi's diabetes new drug enters phase II trials
  • 10/26/2009Pfizer reported to be seeking acquisitions in India
  • 10/15/2009Sundia appoints Senior Vice President of Sales and Marketing
  • 10/13/2009Merck KGaA acquires an Indian bioscience firm Bangalore Genei
  • 9/24/2009MOH advocates integrated community-hospital diabetes management
  • 9/11/2009Amylin and Biocon to co-develop a novel diabetes drug
  • 9/2/2009India rejects IPR of Gilead's Tenofovir (Viread)
  • 8/26/2009Cipla to close an anti-cancer deal with Chinese partner
  • 8/22/2009Jiangsu Hengrui gets USFDA approval for diabetes drug trials
  • 8/14/2009Novo Nordisk and SIBS establish joint research center for prediabetic ...
  • 8/11/2009E&Y: India to lead global pharma outsourcing growth
  • 7/24/2009SIMM awarded a Chinese patent for its compound TCM for diabetes
  • 7/13/2009MOH, CMDA and Bayer launch joint diabetes intervention program in card...
  • 7/10/2009Bayer acquires Chinese rights to Bioton's insulin product
  • 7/9/2009Uni-Bio to initiate phase III trials for Exenatide in China
  • 7/7/2009Novartis loses its Glivec patent fight in India
  • 7/7/2009Sundia MediTech acquires PFSC technology and appoints new VP of drug d...
  • 7/7/2009Pharma outsourcing decision: China or India?
  • 7/5/2009Sundia MediTech appoints senior VP of chemistry
  • 7/3/2009Sundia MediTech appoints new VP of Process Chemistry
  • 6/2/2009Eli Lilly to launched Byetta in China following recent SFDA approval ...
  • 5/27/2009JAMA study: Asia to see sharp rise of diabetes prevalence
  • 5/5/2009Cuban diabetes drug Heberprot-B under registration in China
  • 4/9/2009Indian firms object to safeguard duty on Chinese antibiotics
  • Page:17/19 Total number of articles:549: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group